Correspondence 0001493152-24-013116 from Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings, Inc.
Date: April 4, 2024 · CIK: 0001453593 · Accession: 0001493152-24-013116

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-278413

Date

April 4, 2024

Author

President

Form

CORRESP

Company

Xtant Medical Holdings, Inc.

Letter

Cruiser Lane

Belgrade, Montana 59714

(406) 388-0480

April 4, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, NE

Washington, DC 20549

Attention: Jimmy McNamara

Re: Xtant Medical Holdings, Inc.

Registration Statement on Form S-3

Filed April 1, 2024

File No. 333-278413

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Xtant Medical Holdings, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 8:30 a.m., Eastern Time, on April 8, 2024, or as soon thereafter as is practicable.

The Company requests that it be notified of such effectiveness by a telephone call to Emily Humbert of Fox Rothschild LLP at (612) 607-7076.

Thank you for your assistance in this matter. Should you have any questions, please call Ms. Humbert.

Very
truly yours,
XTANT
MEDICAL HOLDINGS, INC.

Show Raw Text

CORRESP
1
filename1.htm

664
Cruiser Lane

Belgrade,
Montana 59714

(406)
388-0480

April
4, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, NE

Washington,
DC 20549

Attention:
Jimmy McNamara

    Re:
    Xtant
    Medical Holdings, Inc.

    Registration
    Statement on Form S-3

    Filed
    April 1, 2024

    File
    No. 333-278413

    Request
    for Acceleration

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the Securities Act of 1933, as amended, Xtant Medical Holdings, Inc. (the “Company”) hereby respectfully requests
that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 8:30 a.m.,
Eastern Time, on April 8, 2024, or as soon thereafter as is practicable.

The
Company requests that it be notified of such effectiveness by a telephone call to Emily Humbert of Fox Rothschild LLP at (612) 607-7076.

Thank
you for your assistance in this matter. Should you have any questions, please call Ms. Humbert.

    Very
    truly yours,

    XTANT
    MEDICAL HOLDINGS, INC.

    /s/
    Sean E. Browne

    Sean
    E. Browne

    President
    and Chief Executive Officer

    cc:
    Amy
    E. Culbert, Esq.

    Emily
    Humbert, Esq.

SecProbe.io